Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Dow
Medtronic
Harvard Business School
McKinsey

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Sulfisoxazole acetyl - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for sulfisoxazole acetyl and what is the scope of patent protection?

Sulfisoxazole acetyl is the generic ingredient in three branded drugs marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sulfisoxazole acetyl.

Summary for sulfisoxazole acetyl
US Patents:0
Tradenames:3
Applicants:1
NDAs:1
Drug Master File Entries: 3
Bulk Api Vendors: 26
Patent Applications: 1,311
DailyMed Link:sulfisoxazole acetyl at DailyMed
Synonyms for sulfisoxazole acetyl
4-Dimethylisoxazol-5-yl-N-sulphanilylacetamide
80-74-0
AC1L1N11
AC1Q6V7X
Acetamide, N-((4-aminophenyl)sulfonyl)-N-(3,4-dimethyl-5-isoxazolyl)-
Acetamide, N-(3,4-dimethyl-5-isoxazolyl)-N-sulfanilyl-
Acetamide, N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethyl-5-isoxazolyl)-
ACETYL SULFISOXAZOLE
acetylsulfafurazole
Acetylsulfisoxazole
Acetylsulfisoxazole (JAN)
AKOS027427029
AN-24034
API0004283
B4954
C14H16N2O4S
CAS-80-74-0
CHEBI:135975
CHEMBL1200910
D05956
DSSTox_CID_3620
DSSTox_GSID_23620
DSSTox_RID_97551
DTXSID4023620
EINECS 201-305-3
JFNWFXVFBDDWCX-UHFFFAOYSA-N
KS-000001H6
Lipo Gantrisin
Lipo gantrisin (TN)
LS-177521
MolPort-006-147-734
N-((4-Aminophenyl)sulfonyl)-N-(3,4-dimethylisoxazol-5-yl)acetamide
N-(3,4-Dimethyl-5-isoxazolyl)-N-sulfanilylacetamide
N-(4-aminophenyl)sulfonyl-N-(3,4-dimethyl-1,2-oxazol-5-yl)acetamide
N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethyl-5- isoxazolyl)acetamide
N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethylisoxazol-5-yl)acetamide
N-3,4-Dimethylisoxazol-5-yl-N-sulphanilylacetamide
N-Acetyl-4-amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide #
NCGC00249884-01
SCHEMBL41727
Sulfisoxazole acetal
Sulfisoxazole acetyl (USP)
Sulfisoxazole acetyl [USAN]
Sulfisoxazole acetyl [USP]
Tox21_113660
UNII-WBT5QH3KED
WBT5QH3KED
ZINC2114

US Patents and Regulatory Information for sulfisoxazole acetyl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche GANTRISIN sulfisoxazole acetyl SYRUP;ORAL 009182-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roche GANTRISIN PEDIATRIC sulfisoxazole acetyl SUSPENSION;ORAL 009182-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roche LIPO GANTRISIN sulfisoxazole acetyl EMULSION;ORAL 009182-009 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Medtronic
AstraZeneca
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.